Ocugen OCGN
NASDAQ OCGN
$1.36 +0.01 (+0.74%)
At close: Sep 4, 2026 · 4:00 PM EDT

Ocugen (OCGN) Current Deferred Revenue (2014 - 2018)

Ocugen's (OCGN) quarterly Current Deferred Revenue came in at $45000.0 in Q4 2018, up 28.57% YoY from $35000.0 in Q4 2017, and down 99.1% on a QoQ basis from $5.0 million in Q3 2018.

Analysis

Ocugen (OCGN) Current Deferred Revenue (2014 - 2018) Analysis & Trends

Ocugen (OCGN) has 5 years of Current Deferred Revenue data on file, last reported at $45000.0 in Q4 2018.

  • Quarterly Current Deferred Revenue rose 28.57% year-over-year to $45000.0 in Q4 2018, while the trailing twelve-month figure through Dec 2018 was $45000.0 (up 28.57% YoY) and the FY2018 annual result came in at $45000.0, up 28.57% from the prior year.
  • Current Deferred Revenue declined to $45000.0 in Q4 2018, from $5.0 million in the prior quarter.
  • In the past five years, Current Deferred Revenue ranged from a high of $7.5 million in Q2 2018 to a low of $35000.0 in Q4 2017.
  • A 5-year average of $1.1 million and a median of $133000.0 in 2016 frame the typical range for Current Deferred Revenue.
  • Annual changes were most pronounced in 2017 — Current Deferred Revenue tumbled 74.26% — and 2018, when it jumped 8620.93%.
  • Tracing OCGN's Current Deferred Revenue over 5 years: stood at $219000.0 in 2014, then tumbled by 42.47% to $126000.0 in 2015, then rose by 7.94% to $136000.0 in 2016, then plunged by 74.26% to $35000.0 in 2017, then gained by 28.57% to $45000.0 in 2018.
  • The last three Current Deferred Revenue figures came in at $45000.0 (Q4 2018), $5.0 million (Q3 2018), and $7.5 million (Q2 2018), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn
10 Ocugen 458.91 Mn 358.81 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2018 45,000.00
Sep 30, 2018 5.00 Mn
Jun 30, 2018 7.50 Mn
Mar 31, 2018 5.00 Mn
Dec 31, 2017 35,000.00
Sep 30, 2017 60,000.00
Jun 30, 2017 86,000.00
Mar 31, 2017 110,000.00
Dec 31, 2016 136,000.00
Sep 30, 2016 133,000.00
Jun 30, 2016 131,000.00
Mar 31, 2016 128,000.00
Dec 31, 2015 126,000.00
Sep 30, 2015 225,000.00
Jun 30, 2015 223,000.00
Mar 31, 2015 224,000.00
Dec 31, 2014 219,000.00